OXYTROL
- Product NDC
- 52544-920
- 11-digit product format
- 525440920
- Labeler code
- 52544
- Product ID
- 52544-920_f59c07ba-71fe-4a49-aa7e-f34b077df010
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxybutynin
- Dosage form
- PATCH
- Route
- TRANSDERMAL
- Labeler
- Actavis Pharma, Inc.
- Application
- NDA021351
- Marketing category
- NDA
- Marketing start
- 2003-02-26
- Marketing end
- 2020-01-31
- Substance
- OXYBUTYNIN
- Active strength
- 4 mg/d
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 52544-920 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | a1b67e2a42f9… | c4cf2c586c0d… | ||
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | cfe11265f3b6… | 090c488252e2… | ||
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | cdf11ea48f46… | ba0047e9e063… | ||
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | cdf11ea48f46… | ba0047e9e063… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… | ||
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | ||
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… | ||
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | ad56d346431e… | cc804d4bbf1e… | ||
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | ad56d346431e… | cc804d4bbf1e… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… | ||
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 52544-920 | D | Discontinued by firm | excluded / ndc_excluded.zip | 557ba5c1ecfa… | 9c80585c8c6e… | ||
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 52544-920 | 52544-920-08 | D | Discontinued by firm | excluded / ndc_excluded.zip | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021351-002 | OXYTROL | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021351-002 | OXYTROL | 3.9MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2003-02-26 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021351-002 | 6743441 | 2020-04-26 | U-318 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021351-002 | 7081249 | 2020-04-26 | U-318 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021351-002 | 7081250 | 2020-04-26 | U-318 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021351-002 | 7081251 | 2020-04-26 | U-318 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021351-002 | 7081252 | 2020-04-26 | U-318 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021351-002 | 7179483 | 2020-04-26 | U-318 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021351-002 | 6743441 | 2020-04-26 | U-318 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021351-002 | 7081249 | 2020-04-26 | U-318 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021351-002 | 7081250 | 2020-04-26 | U-318 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021351-002 | 7081251 | 2020-04-26 | U-318 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021351-002 | 7081252 | 2020-04-26 | U-318 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021351-002 | 7179483 | 2020-04-26 | U-318 | Drug substance, Drug product | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021351-002 | 6743441 | 2020-04-26 | U-318 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021351-002 | 7081249 | 2020-04-26 | U-318 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021351-002 | 7081250 | 2020-04-26 | U-318 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021351-002 | 7081251 | 2020-04-26 | U-318 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021351-002 | 7081252 | 2020-04-26 | U-318 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021351-002 | 7179483 | 2020-04-26 | U-318 | Drug substance, Drug product | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021351-002 | 6743441 | 2020-04-26 | U-318 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021351-002 | 7081249 | 2020-04-26 | U-318 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021351-002 | 7081250 | 2020-04-26 | U-318 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021351-002 | 7081251 | 2020-04-26 | U-318 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021351-002 | 7081252 | 2020-04-26 | U-318 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021351-002 | 7179483 | 2020-04-26 | U-318 | Drug substance, Drug product | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021351-002 | 6743441 | 2020-04-26 | U-318 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021351-002 | 7081249 | 2020-04-26 | U-318 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021351-002 | 7081250 | 2020-04-26 | U-318 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021351-002 | 7081251 | 2020-04-26 | U-318 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021351-002 | 7081252 | 2020-04-26 | U-318 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021351-002 | 7179483 | 2020-04-26 | U-318 | Drug substance, Drug product | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021351-002 | 6743441 | 2020-04-26 | U-318 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021351-002 | 7081249 | 2020-04-26 | U-318 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021351-002 | 7081250 | 2020-04-26 | U-318 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021351-002 | 7081251 | 2020-04-26 | U-318 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021351-002 | 7081252 | 2020-04-26 | U-318 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021351-002 | 7179483 | 2020-04-26 | U-318 | Drug substance, Drug product | ea99ee380514… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXYTROL | OXYBUTYNIN | Allergan, Inc. | 20dee37f-1412-44ed-9e8b-f4379ce23eb0 | 2024-05-29 | Warnings, Adverse reactions | 021351 NDA021351 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52544-920-08 | EA - Each | 52544-920 | e4188f57-f61e-4bcc-866e-ba52a5b19350 | 1 | 2012-07-24 |
| 52544-920-54 | EA - Each | 52544-920 | 8ec4ce37-c1c6-4ed5-ac70-0c180f421236 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OXYBUTYNIN | ACTIVE INGREDIENT | K9P6MC7092 | OXYTROL (OXYBUTYNIN) PATCH [ACTAVIS PHARMA, INC.] | 18 | |
| OXYBUTYNIN | ACTIVE MOIETY | K9P6MC7092 | OXYTROL (OXYBUTYNIN) PATCH [ACTAVIS PHARMA, INC.] | 18 | |
| TRIACETIN | INACTIVE INGREDIENT | XHX3C3X673 | OXYTROL (OXYBUTYNIN) PATCH [ACTAVIS PHARMA, INC.] | 18 |